Karin Somby

PhD student
Novartis Pharma AG, Switzerland

Karin Somby is a final-year PhD student at Novartis Pharma AG in Basel, Switzerland, in association with King's College London. Her PhD research focuses on subcutaneous biopharmaceutics for oligonucleotides, including developing in vitro-in vivo correlations. Karin holds a First Class MSci in Pharmaceutical Chemistry from Queen Mary University of London.

Disclosure information not submitted.

Presentation(s):

• The SCISSOR technology: Investigating Biopharmaceutics of Subcutaneously Delivered Oligonucleotides

  Wednesday, July 16, 2025
  3:27 PM - 3:38 PM EDT